
CancerNetwork® spoke with Vivek Subbiah, MD, during the virtual American Association for Cancer Research Annual Meeting 2021 to discuss the most important data to come out of the meeting regarding therapy for tumors harboring KRAS mutations.

Your AI-Trained Oncology Knowledge Connection!


Published: April 17th 2021 | Updated: